Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma ; volume:11 ; number:1 ; day:11 ; month:4 ; year:2011 ; pages:1-12 ; date:12.2011
BMC cancer ; 11, Heft 1 (11.4.2011), 1-12, 12.2011
- Creator
-
Andolfo, Immacolata
- Contributor
-
Petrosino, Giuseppe
Vecchione, Loredana
De Antonellis, Pasqualino
Capasso, Mario
Montanaro, Donatella
Gemei, Marica
Troncone, Giancarlo
Iolascon, Achille
Orditura, Michele
Ciardiello, Fortunato
De Vita, Fernando
Zollo, Massimo
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-11-126
- URN
-
urn:nbn:de:1111-2016030365149
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Andolfo, Immacolata
- Petrosino, Giuseppe
- Vecchione, Loredana
- De Antonellis, Pasqualino
- Capasso, Mario
- Montanaro, Donatella
- Gemei, Marica
- Troncone, Giancarlo
- Iolascon, Achille
- Orditura, Michele
- Ciardiello, Fortunato
- De Vita, Fernando
- Zollo, Massimo
- SpringerLink (Online service)
Other Objects (12)
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Genetische Analyse des Tyrosinkinase-Rezeptors ErbB2
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Treatment of ErbB2 breast cancer by mitochondrial targeting
Nuclear ErbB2 expression in hepatocytes in liver disease
Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer